According to Edwards Lifesciences's latest financial reports the company has a price-to-book ratio of 7.74.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 6.88 | -13.36% |
2022-12-31 | 7.94 | -42.68% |
2021-12-31 | 13.9 | 11.5% |
2020-12-31 | 12.4 | 5.7% |
2019-12-31 | 11.8 | 16.08% |
2018-12-31 | 10.1 | 25.56% |
2017-12-31 | 8.07 | 5.47% |
2016-12-31 | 7.65 | 12.55% |
2015-12-31 | 6.80 | 8.46% |
2014-12-31 | 6.27 | 34.64% |
2013-12-31 | 4.65 | -33.2% |
2012-12-31 | 6.97 | 15.58% |
2011-12-31 | 6.03 | -15.17% |
2010-12-31 | 7.11 | 66.8% |
2009-12-31 | 4.26 | 22.41% |
2008-12-31 | 3.48 | 11.65% |
2007-12-31 | 3.12 | -13.93% |
2006-12-31 | 3.62 | 0.9% |
2005-12-31 | 3.59 | -8.07% |
2004-12-31 | 3.90 | 38.6% |
2003-12-31 | 2.82 | -0.86% |
2002-12-31 | 2.84 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Medtronic MDT | 2.02 | -73.89% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 5.07 | -34.48% | ๐บ๐ธ USA |
Merit Medical MMSI | 3.43 | -55.72% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | 4.72 | -39.07% | ๐บ๐ธ USA |
ICU Medical
ICUI | 1.11 | -85.64% | ๐บ๐ธ USA |